Article Details
Retrieved on: 2022-12-09 14:40:11
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Jazz Pharmaceuticals (JAZZ) traded higher pre-market Friday after Goldman Sachs upgraded the Ireland-based biopharma to Buy from Neutral.
Article found on: seekingalpha.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here